Stem Cell Stocks Higher on Breakthrough Study

Shares of some stem cell companies are higher today following breakthrough studies in US and Japan which turned ordinary human skin cells into stem cells. The reprogrammed cells from the study can become any cell in the human body, which is the same trait as controversial embryonic stem cells.

Stem Cell Stocks: Aastrom Biosciences Inc (Nasdaq: ASTM), StemCells Inc (Nasdaq: STEM), Geron Corporation's (Nasdaq: GERN), Cytori Therapeutics, Inc. (Nasdaq: CYTX).

You May Also Be Interested In

• SK Hynix picks Nasdaq for U.S. share listing - Reuters
• ECB governors likely to pause rate hikes in July meeting - Reuters
• SpaceX's IPO Draws at Least $5B Order From BlackRock - WSJ